A Phase IIa Dose Escalation Pilot Study to Investigate the Safety and Tolerability of Intranasal Insulin in Subjects With Diabetic Polyneuropathy.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Insulin (Primary)
- Indications Diabetic neuropathies
- Focus Adverse reactions
- Acronyms IIDPN
- 10 Aug 2012 Biomarkers information updated
- 09 Aug 2012 Actual end date (Jul 2012) added as reported by ClinicalTrials.gov.
- 31 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.